サル痘ワクチンと治療の市場規模、シェア、動向分析レポート：製品別（ワクチン、薬剤、ワクチン免疫グロブリン）、性別、投与経路別、最終用途別、地域別、セグメント別予測、2022年～2030年

サル痘ワクチンと治療の市場成長と動向

Grand View Research, Inc.の新しいレポートによると、世界のサル痘ワクチンと治療の市場規模は2030年までに1億8479万米ドルに達し、2022年から2030年までCAGR10.16%で拡大すると予測されています。サル痘ウイルスの脅威に対抗するための政府の取り組みが活発化していることや、この病気に関する認知度が急上昇していることが、市場を牽引する主な要因となっています。さらに、ワクチンや治療法を開発するための研究開発活動が活発化していることも、市場成長の原動力となることが期待されています。

感染症の発症率は、女性に比べ男性で高くなっています。CDCの2021年8月のデータによると、31歳から35歳の女性11人に対し、31歳から35歳の男性2,231人以上がサル痘ウイルスに感染しています。このウイルスの感染率は、20～50歳代に多く見られると推測されます。このように、サル痘ウイルスによる感染率の上昇は、新規かつ効果的な治療法の需要を促進すると予想されます。

研究活動を後押しし、ワクチン工場の製造能力を拡大するための資金調達が増加していることは、市場の需要を後押しすると思われます。例えば、2022年8月、米国保健社会福祉省は、ミシガン州GRAMでサル痘と天然痘を予防するために承認されたJYNNEOSワクチンの充填と製造終了のための支援を提供するために1100万米ドルの資金提供を発表しました。この資金は、GRAMがJYNNEOS製造のための追加設備を購入するための支援となります。

さらに、2022年7月、パンデミック研究所は、サル痘の世界の脅威を管理するために、リバプールの研究者に約580,049米ドルの資金を授与しました。この資金は、この病気にまつわるスティグマを理解し、新しい治療レジメンを開発するための研究活動を推進するために授与されるものです。

さらに、主要な市場プレーヤーが自社のポートフォリオと市場の足跡を強化するために行っているさまざまな戦略的イニシアティブは、市場の拡大を促進すると予想されます。例えば、2022年8月、Bavarian Nordic A/Sは、カリブ海およびラテンアメリカの国々に対するBavarian Nordic A/Sのサル痘ワクチンへの公平なアクセスを後押しするための汎アメリカ保健機構との合意を発表しました。ワクチンの納入は9月に開始されるようです。

また、2022年5月、SIGA Technologies, Inc.は、点滴製剤TPOXX（tecovirimat）が天然痘の治療薬として米国FDAの承認を取得したと発表しました。点滴製剤は、経口製剤であるTPOXXを飲み込めない患者のための代替品です。米国では、TPOXXの静脈内投与製剤は、サル痘の症状管理にも使用されています。

しかし、ワクチンによる副作用の可能性が、今後数年間の市場成長の妨げになる可能性があります。サル痘ワクチンに関連する一般的な副作用には、硬結、筋肉痛、腫脹、吐き気、痒みなどがあります。

サル痘ワクチンと治療市場レポートハイライト

製品別では、進行中の製品承認と治療用抗ウイルス薬の需要増加により、医薬品セグメントが2022年に最大のシェアを占めた

男性の感染率が高いことから、男性向けが2022年に最大シェアを占めました。

投与経路別では、サル痘治療のための経口抗ウイルス薬の需要増加により、経口セグメントが2022年に市場を独占した

2022年は病院セグメントが最大。専門クリニックセグメントは、予測期間を通じて最も速い成長率を記録すると予想される

アジア太平洋地域は、サル痘感染症のリスク増加やワクチン接種に関する意識の高まりから、予測期間を通じて最も速い成長率を示すと予想される

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • セグメントの範囲
  • 地域範囲
• 調査手法
• 情報調達
  • 購入したデータベース：
  • GVRの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査内容
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
  • コモディティフロー分析
    • アプローチ：商品フローアプローチ
• 調査の仮定
• 二次情報一覧
• 略語一覧
• 目的

第2章 エグゼクティブサマリー

• 市場の見通し
• 競合考察

第3章 サル痘ワクチンと治療市場：変数、動向、および範囲

• 市場系列の見通し
  • 親市場
• 市場力学
  • 市場促進要因分析
    • サル痘感染症の有病率の増加
    • サル痘の流行に対抗するための政府の取り組み
  • 市場抑制要因分析
    • ワクチンと治療に伴う副作用
• 浸透と成長の見通しのマッピング
• サル痘のワクチンと治療：市場分析ツール
  • 業界分析- ポーターズ
  • PESTLE分析
• 規制の枠組み
• 価格分析

第4章 サル痘ワクチンと治療市場：セグメント分析、製品別、2022年から2030年（100万米ドル）

• 定義と範囲
• 製品市場シェア分析、2022年および2030年
• セグメントダッシュボード
• 世界のサル痘ワクチンと治療市場、製品別、2022年から2030年
• 市場規模と予測、トレンド分析、2022年から2030年
  • ワクチン
    • JYNNEOS/インバネクス
    • 天然痘ワクチン
    • その他
  • 薬物
    • テコビリマト
    • ブリンシドフォビル
    • シドフォビル
    • その他
  • ワクシニア免疫グロブリン（VIG）

第5章 サル痘ワクチンと治療市場：セグメント分析、投与経路別2022年から2030年（100万米ドル）

• 定義と範囲
• 投与経路の市場シェア分析、2022年および2030年
• セグメントダッシュボード
• 2022年から2030年までの投与経路別の世界のサル痘ワクチンと治療市場
• 市場規模と予測、トレンド分析、2022年から2030年
  • オーラル
  • 注射可能

第6章 サル痘ワクチンと治療市場：セグメント分析、性別、2022年から2030年（100万米ドル）

• 定義と範囲
• 性別市場シェア分析、2022年および2030年
• セグメントダッシュボード
• 2022年から2030年までの男女別の世界のサル痘ワクチンと治療市場
• 市場規模と予測、トレンド分析、2022年から2030年
  • 男
  • 女性
  • その他

第7章 サル痘ワクチンと治療市場：セグメント分析、最終用途別、2022年から2030年（100万米ドル）

• 定義と範囲
• 最終用途の市場シェア分析、2022年および2030年
• セグメントダッシュボード
• 2022年から2030年までの最終用途別の世界のサル痘ワクチンと治療市場
• 市場規模と予測、トレンド分析、2022年から2030年
  • 病院
  • 専門クリニック
  • その他

第8章 サル痘ワクチンと治療市場：セグメント分析、地域別、2022年から2030年（100万米ドル）

• 定義と範囲
• 地域市場シェア分析、2022年および2030年
• 地域市場ダッシュボード
• 地域市場のスナップショット
• SWOT分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東とアフリカ
• 市場規模、予測、収益、トレンド分析：2022年から2030年
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • MEA
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第9章 サル痘ワクチンと治療市場：競合分析

• 最近の動向と影響分析：主要な市場参入企業別
  • Ansoff matrix
  • Heat map analysis
  • Major Deals and Strategic Alliances Analysis
    • 合弁事業
    • ライセンシング契約
    • 製品の発売
    • カンファレンスとキャンペーン
• 会社の分類
  • イノベーター
  • 市場のリーダー
• ベンダー情勢
  • 主要なディストリビューターとチャネルパートナーのリスト
  • 主要顧客
• 公開会社
  • 競合ダッシュボード分析
    • 市場の差別化要因
• 非公開会社
  • 主要新興企業一覧
• 企業プロファイル
  • Bavarian Nordic
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • SIGA Technologies
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Chimerix
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • EMERGENT
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Gilead Sciences, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Leading Market Players Anticipated to Witness Highest Growth
• Table 4 Global Monkeypox Vaccine and Treatment Market, By Region, 2022 - 2030 (USD Million)
• Table 5 Global Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 6 Global Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 7 Global Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 8 Global Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 9 North America Monkeypox Vaccine and Treatment Market, By Country, 2022 - 2030 (USD Million)
• Table 10 North America Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 11 North America Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 12 North America Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 13 North America Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 14 U.S. Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 15 U.S. Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 16 U.S. Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 17 U.S. Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 18 Canada Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 19 Canada Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 20 Canada Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 21 Canada Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 22 Europe Monkeypox Vaccine and Treatment Market, By Country, 2022 - 2030 (USD Million)
• Table 23 Europe Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 24 Europe Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 25 Europe Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 26 Europe Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 27 Germany Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 28 Germany Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 29 Germany Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 30 Germany Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 31 U.K. Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 32 U.K. Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 33 U.K. Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 34 U.K. Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 35 France Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 36 France Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 37 France Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 38 France Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 39 Italy Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 40 Italy Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 41 Italy Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 42 Italy Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 43 Spain Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 44 Spain Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 45 Spain Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 46 Spain Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 47 Asia Pacific Monkeypox Vaccine and Treatment Market, By Country, 2022 - 2030 (USD Million)
• Table 48 Asia Pacific Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 49 Asia Pacific Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 50 Asia Pacific Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 51 Asia Pacific Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 52 Japan Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 53 Japan Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 54 Japan Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 55 Japan Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 56 China Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 57 China Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 58 China Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 59 China Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 60 India Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 61 India Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 62 India Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 63 India Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 64 South Korea Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 65 South Korea Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 66 South Korea Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 67 South Korea Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 68 Australia Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 69 Australia Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 70 Australia Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 71 Australia Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 72 Latin America Monkeypox Vaccine and Treatment Market, By Country, 2022 - 2030 (USD Million)
• Table 73 Latin America Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 74 Latin America Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 75 Latin America Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 76 Latin America Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 77 Mexico Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 78 Mexico Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 79 Mexico Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 80 Mexico Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 81 Brazil Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 82 Brazil Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 83 Brazil Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 84 Brazil Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 85 Argentina Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 86 Argentina Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 87 Argentina Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 88 Argentina Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 89 Middle East and Africa Monkeypox Vaccine and Treatment Market, By Country, 2022 - 2030 (USD Million)
• Table 90 Middle East and Africa Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 91 Middle East and Africa Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 92 Middle East and Africa Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022-203(USD Million)
• Table 93 Middle East and Africa Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 94 South Africa Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 95 South Africa Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 96 South Africa Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 97 South Africa Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 98 Saudi Arabia Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 99 Saudi Arabia Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 100 Saudi Arabia Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 101 Saudi Arabia Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)
• Table 102 UAE Monkeypox Vaccine and Treatment Market, By Product, 2022 - 2030 (USD Million)
• Table 103 UAE Monkeypox Vaccine and Treatment Market, By Gender, 2022 - 2030 (USD Million)
• Table 104 UAE Monkeypox Vaccine and Treatment Market, By Route of Administration, 2022 - 2030 (USD Million)
• Table 105 UAE Monkeypox Vaccine and Treatment Market, By End-use, 2022 - 2030 (USD Million)

List of Figures

• Fig. 1 Monkeypox vaccine and treatment market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2022)
• Fig. 10 Strategy framework
• Fig. 11 Market driver relevance analysis (Current & future impact)
• Fig. 12 Market restraint relevance analysis (Current & future impact)
• Fig. 13 Penetration & growth prospect mapping
• Fig. 14 Porter's five forces analysis
• Fig. 15 PESTLE analysis
• Fig. 16 Monkeypox vaccine and treatment market: Product movement analysis
• Fig. 17 Monkeypox vaccine and treatment market: Product segment dashboard
• Fig. 18 Monkeypox vaccine and treatment market product outlook: Key takeaways
• Fig. 19 Vaccine market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 20 JYNNEOS/ Imvanex market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 21 Smallpox vaccine market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 22 Others market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 23 Drugs market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 24 Tecovirimat market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 25 Brincidofovir market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 26 Cidofovir market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 27 Others market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 28 Vaccinia Immune Globulin (VIG) market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 29 Monkeypox vaccine and treatment market: Gender analysis
• Fig. 30 Monkeypox vaccine and treatment market: Gender segment dashboard
• Fig. 31 Monkeypox vaccine and treatment market gender outlook: Key takeaways
• Fig. 32 Male market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 33 Female market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 34 Others market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 35 Monkeypox vaccine and treatment market: Route of administration movement analysis
• Fig. 36 Monkeypox vaccine and treatment market: Route of administration segment dashboard
• Fig. 37 Monkeypox vaccine and treatment market, route of administration outlook: Key takeaways
• Fig. 38 Oral market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 39 Injectables market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 40 Monkeypox vaccine and treatment market: End-use movement analysis
• Fig. 41 Monkeypox vaccine and treatment market: End-use segment dashboard
• Fig. 42 Monkeypox vaccine and treatment market, end-use outlook: Key takeaways
• Fig. 43 Hospitals market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 44 Specialty clinics market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 45 Others market estimates and forecasts, 2022 - 2030 (USD Million)
• Fig. 46 Regional outlook estimates and forecasts, 2022 & 2030
• Fig. 47 Regional market dashboard
• Fig. 48 Regional marketplace: Key takeaways
• Fig. 49 North America, SWOT
• Fig. 50 Europe, SWOT
• Fig. 51 Asia Pacific, SWOT
• Fig. 52 Latin America, SWOT
• Fig. 53 Middle East and Africa, SWOT
• Fig. 54 North America
• Fig. 55 North America monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 56 U.S.
• Fig. 57 U.S. monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 58 Canada
• Fig. 59 Canada monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 60 Europe
• Fig. 61 Europe monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 62 U.K.
• Fig. 63 U.K. monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 64 Germany
• Fig. 65 Germany monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 66 Spain
• Fig. 67 Spain monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 68 France
• Fig. 69 France monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 70 Italy
• Fig. 71 Italy monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 72 Russia
• Fig. 73 Russia monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 74 Asia Pacific
• Fig. 75 Asia Pacific monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 76 Japan
• Fig. 77 Japan monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 78 China
• Fig. 79 China monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 80 India
• Fig. 81 India monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 82 South Korea
• Fig. 83 South Korea monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 84 Australia
• Fig. 85 Australia monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 86 Latin America
• Fig. 87 Latin America monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 88 Brazil
• Fig. 89 Brazil monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 90 Mexico
• Fig. 91 Mexico monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 92 Argentina
• Fig. 93 Argentina monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 94 Middle East and Africa
• Fig. 95 MEA monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 96 South Africa
• Fig. 97 South Africa monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 98 Saudi Arabia
• Fig. 99 Saudi Arabia monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 100 UAE
• Fig. 101 UAE monkeypox vaccine and treatment market, 2022 - 2030 (USD Million)
• Fig. 102 Ansoff Matrix
• Fig. 103 Heat map analysis
• Fig. 104 Market differentiators

Monkeypox Vaccine And Treatment Market Growth & Trends:

The global monkeypox vaccine and treatment market size is expected to reach USD 184.79 million by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.16% from 2022 to 2030. The growing government initiatives for combating the monkeypox virus threat and a surge in awareness about the disease are the major factors driving the market. Moreover, an increase in R&D activities to develop vaccines and treatments is expected to fuel market growth.

The incidence rate of infection is higher in men as compared to women. According to the CDC's data of August 2021, the monkeypox virus affected over 2,231 men of age 31 to 35 as compared to 11 women of age 31 to 35. The infection rate of the virus is more common in people between 20 to 50 years of age. Thus, the rising infection rates from the monkeypox virus are anticipated to fuel the demand for novel and effective treatment.

The increasing funding for boosting research activities and expanding manufacturing capacities of vaccine plants is likely to fuel market demand. For instance, in August 2022, the U.S. Department of Health and Human Services announced a funding of USD 11 million for providing support to fill and finish the manufacturing of JYNNEOS vaccine approved for preventing monkeypox and smallpox at GRAM, Michigan. This funding will assist GRAM to purchase extra equipment for JYNNEOS production.

Moreover, in July 2022, the pandemic institute awarded funding of around USD 580,049 to Liverpool researchers for managing the global threat of monkeypox. The funding is awarded for promoting research activities for understanding the stigma around the disease and developing new treatment regimens.

Furthermore, various strategic initiatives undertaken by the leading market players to strengthen their portfolio and market footprint are expected to facilitate market expansion. For instance, in August 2022, Bavarian Nordic A/S announced an agreement with Pan American Health Organization to boost equitable access to the Bavarian Nordic A/S monkeypox vaccine for countries in the Caribbean and Latin America. The vaccine delivery is likely to commence in the month of September.

In addition, in May 2022, SIGA Technologies, Inc. announced that its IV formulation TPOXX (tecovirimat) received U.S. FDA approval for the treatment of smallpox. The intravenous formulation is an alternative for patients who cannot swallow the oral formulation of the TPOXX. The IV formulation of TPOXX is also being used to manage the symptoms of monkeypox in the U.S.

However, the chances of side effects from the vaccine may hinder the market growth in the coming years. Some of the common side effects associated with the monkeypox vaccine include induration, muscle pain, swelling, nausea, and itching, among others.

Monkeypox Vaccine And Treatment Market Report Highlights:

• Based on product, the drugs segment held the largest share in 2022 owing to ongoing product approvals and increasing demand for antiviral drugs for the treatment

• The male segment accounted for the largest share in 2022 due to the higher prevalence of infections among men

• By route of administration, the oral segment dominated the market in 2022 due to the increased demand for oral antiviral drugs for the treatment of monkeypox disease

• The hospitals segment was the largest segment in 2022. The specialty clinics segment is anticipated to register the fastest growth rate throughout the forecast period

• Asia Pacific is expected to exhibit the fastest growth rate over the forecast period due to the increased risk of monkeypox infections and increasing awareness about vaccination

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Segment scope
  • 1.1.2 Regional scope
  • 1.1.3 Estimates and forecast timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased database:
  • 1.3.2 GVR's internal database
  • 1.3.3 Secondary sources
  • 1.3.4 Primary research
  • 1.3.5 Details of primary research
• 1.4 Information or Data Analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach: Commodity Flow Approach
• 1.7 Research Assumptions
• 1.8 List of Secondary Sources
• 1.9 List of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Competitive Insights

Chapter 3 Monkeypox Vaccine and Treatment Market Variables, Trends, & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent market
• 3.2 Market Dynamics
  • 3.2.1 Market drivers analysis
    • 3.2.1.1 Increase in prevalence of monkeypox infection
    • 3.2.1.2 Government initiatives to combat outbreak of monkeypox
  • 3.2.2 Market restraint analysis
    • 3.2.2.1 Side effects associated with the vaccine and treatment
• 3.3 Penetration & Growth Prospect Mapping
• 3.4 Monkeypox Vaccine and Treatment: Market Analysis Tools
  • 3.4.1 Industry analysis - Porter's
  • 3.4.2 PESTLE analysis
• 3.5 Regulatory Framework
• 3.6 Pricing Analysis

Chapter 4 Monkeypox Vaccine and Treatment Market Segment Analysis, By Product, 2022 - 2030 (USD Million)

• 4.1 Definition and Scope
• 4.2 Product Market Share Analysis, 2022 & 2030
• 4.3 Segment Dashboard
• 4.4 Global Monkeypox Vaccine and Treatment Market, by Product, 2022 to 2030
• 4.5 Market Size & Forecasts and Trend Analyses, 2022 to 2030
  • 4.5.1 Vaccine
    • 4.5.1.1 Vaccine market estimates and forecasts, 2022 - 2030 (USD Million)
    • 4.5.1.1.1 JYNNEOS/Imvanex
    • 4.5.1.1.1.1 JYNNEOS/Imvanex market estimates and forecasts, 2022 - 2030 (USD Million)
    • 4.5.1.1.2 Smallpox Vaccine
    • 4.5.1.1.2.1 Smallpox vaccine market estimates and forecasts, 2022 - 2030 (USD Million)
    • 4.5.1.1.3 Others
    • 4.5.1.1.3.1 Others market estimates and forecasts, 2022 - 2030 (USD Million)
  • 4.5.2 Drugs
    • 4.5.2.1 Drugs market estimates and forecasts, 2022 - 2030 (USD Million)
    • 4.5.2.1.1 Tecovirimat
    • 4.5.2.1.1.1 Tecovirimat market estimates and forecasts, 2022 - 2030 (USD Million)
    • 4.5.2.1.2 Brincidofovir
    • 4.5.2.1.2.1 Brincidofovir market estimates and forecasts, 2022 - 2030 (USD Million)
    • 4.5.2.1.3 Cidofovir
    • 4.5.2.1.3.1 Cidofovir market estimates and forecasts, 2022 - 2030 (USD Million)
    • 4.5.2.1.4 Others
    • 4.5.2.1.4.1 Others market estimates and forecasts, 2022 - 2030 (USD Million)
  • 4.5.3 Vaccinia Immune Globulin (VIG)
    • 4.5.3.1 Vaccinia Immune Globulin (VIG)market estimates and forecasts, 2022 - 2030 (USD Million)

Chapter 5 Monkeypox Vaccine and Treatment Market Segment Analysis, By Route of Administration2022 - 2030 (USD Million)

• 5.1 Definition and Scope
• 5.2 Route of Administration Market Share Analysis, 2022 & 2030
• 5.3 Segment Dashboard
• 5.4 Global Monkeypox Vaccine and Treatment Market, by Route of Administration, 2022 to 2030
• 5.5 Market Size & Forecasts and Trend Analyses, 2022 to 2030
  • 5.5.1 Oral
    • 5.5.1.1 Oral market estimates and forecasts, 2022 - 2030 (USD Million)
  • 5.5.2 Injectable
    • 5.5.2.1 Injectable market estimates and forecasts, 2022 - 2030 (USD Million)

Chapter 6 Monkeypox Vaccine and Treatment Market Segment Analysis, By Gender, 2022 - 2030 (USD Million)

• 6.1 Definition and Scope
• 6.2 Gender Market Share Analysis, 2022 & 2030
• 6.3 Segment Dashboard
• 6.4 Global Monkeypox Vaccine and Treatment Market, by Gender, 2022 to 2030
• 6.5 Market Size & Forecasts and Trend Analyses, 2022 to 2030
  • 6.5.1 Male
    • 6.5.1.1 Male market estimates and forecasts, 2022 - 2030 (USD Million)
  • 6.5.2 Female
    • 6.5.2.1 Female market estimates and forecasts, 2022 - 2030 (USD Million)
  • 6.5.3 Others
    • 6.5.3.1 Others market estimates and forecasts, 2022 - 2030 (USD Million)

Chapter 7 Monkeypox Vaccine and Treatment Market Segment Analysis, By End-use, 2022 - 2030 (USD Million)

• 7.1 Definition and Scope
• 7.2 End-use Market Share Analysis, 2022 & 2030
• 7.3 Segment Dashboard
• 7.4 Global Monkeypox Vaccine and Treatment Market, by End-use, 2022 to 2030
• 7.5 Market Size & Forecasts and Trend Analyses, 2022 to 2030
  • 7.5.1 Hospitals
    • 7.5.1.1 Hospitals market estimates and forecasts, 2022 - 2030 (USD Million)
  • 7.5.2 Specialty Clinics
    • 7.5.2.1 Specialty clinics market estimates and forecasts, 2022 - 2030 (USD Million)
  • 7.5.3 Others
    • 7.5.3.1 Others market estimates and forecasts, 2022 - 2030 (USD Million)

Chapter 8 Monkeypox Vaccine and Treatment Market Segment Analysis, By Region, 2022 - 2030 (USD Million)

• 8.1 Definition & Scope
• 8.2 Regional Market Share Analysis, 2022 & 2030
• 8.3 Regional Market Dashboard
• 8.4 Regional Market Snapshot
• 8.5 SWOT Analysis
  • 8.5.1 North America
  • 8.5.2 Europe
  • 8.5.3 Asia Pacific
  • 8.5.4 Latin America
  • 8.5.5 Middle East and Africa
• 8.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
  • 8.6.1 North America
    • 8.6.1.1 North America market estimates and forecast, 2022-2030 (USD Million)
    • 8.6.1.2 U.S.
    • 8.6.1.2.1 U.S. monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
    • 8.6.1.3 Canada
    • 8.6.1.3.1 Canada monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
  • 8.6.2 Europe
    • 8.6.2.1 Europe monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
    • 8.6.2.2 U.K.
    • 8.6.2.2.1 U.K. monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
    • 8.6.2.3 Germany
    • 8.6.2.3.1 Germany monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
    • 8.6.2.4 Spain
    • 8.6.2.4.1 Spain monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
    • 8.6.2.5 France
    • 8.6.2.5.1 France monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
    • 8.6.2.6 Italy
    • 8.6.2.6.1 Italy monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
  • 8.6.3 Asia Pacific
    • 8.6.3.1 Asia Pacific monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
    • 8.6.3.2 Japan
    • 8.6.3.2.1 Japan monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
    • 8.6.3.3 China
    • 8.6.3.3.1 China monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
    • 8.6.3.4 India
    • 8.6.3.4.1 India monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
    • 8.6.3.5 South Korea
    • 8.6.3.5.1 South Korea monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
    • 8.6.3.6 Australia
    • 8.6.3.6.1 Australia monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
  • 8.6.4 Latin America
    • 8.6.4.1 Latin America monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
    • 8.6.4.2 Brazil
    • 8.6.4.2.1 Brazil monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
    • 8.6.4.3 Mexico
    • 8.6.4.3.1Mexico monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
    • 8.6.4.4 Argentina
    • 8.6.4.4.1 Argentina monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
  • 8.6.5 MEA
    • 8.6.5.1 MEA monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
    • 8.6.5.2 South Africa
    • 8.6.5.2.1 South Africa monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
    • 8.6.5.3 Saudi Arabia
    • 8.6.5.3.1 Saudi Arabia monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)
    • 8.6.5.4 UAE
    • 8.6.5.4.1 UAE monkeypox vaccine and treatment market estimates and forecasts, 2022 - 2030 (USD Million)

Chapter 9 Monkeypox Vaccine and Treatment Market - Competitive Analysis

• 9.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 9.1.1 Ansoff matrix
  • 9.1.2 Heat map analysis
  • 9.1.3 Major Deals and Strategic Alliances Analysis
    • 9.1.3.1 Joint Ventures
    • 9.1.3.2 Licensing Agreements
    • 9.1.3.3 Product Launches
    • 9.1.3.4 Conferences and Campaigns
• 9.2 Company Categorization
  • 9.2.1 Innovators
  • 9.2.2 Market Leaders
• 9.3 Vendor Landscape
  • 9.3.1 List of key distributors and channel partners
  • 9.3.2 Key customers
• 9.4 Public Companies
  • 9.4.1 Competitive Dashboard Analysis
    • 9.4.1.1 Market Differentiators
• 9.5 Private Companies
  • 9.5.1 List of key emerging companies
• 9.6 Company Profiles
  • 9.6.1 Bavarian Nordic
    • 9.6.1.1 Company overview
    • 9.6.1.2 Financial performance
    • 9.6.1.3 Product benchmarking
    • 9.6.1.4 Strategic Initiatives
  • 9.6.2 SIGA Technologies
    • 9.6.2.1 Company overview
    • 9.6.2.2 Financial performance
    • 9.6.2.3 Product benchmarking
    • 9.6.2.4 Strategic Initiatives
  • 9.6.3 Chimerix
    • 9.6.3.1 Company overview
    • 9.6.3.2 Financial performance
    • 9.6.3.3 Product benchmarking
    • 9.6.3.4 Strategic Initiatives
  • 9.6.4 EMERGENT
    • 9.6.4.1 Company overview
    • 9.6.4.2 Financial performance
    • 9.6.4.3 Product benchmarking
    • 9.6.4.4 Strategic Initiatives
  • 9.6.5 Gilead Sciences, Inc.
    • 9.6.5.1 Company overview
    • 9.6.5.2 Financial performance
    • 9.6.5.3 Product benchmarking
    • 9.6.5.4 Strategic Initiatives